Estimation of relative biological effectiveness of

RBE Radiopharmaceutical therapy [177Lu]Lu-PSMA [225Ac]Ac-PSMA mCRPC

Journal

EJNMMI physics
ISSN: 2197-7364
Titre abrégé: EJNMMI Phys
Pays: Germany
ID NLM: 101658952

Informations de publication

Date de publication:
11 Sep 2023
Historique:
received: 21 03 2023
accepted: 07 08 2023
medline: 11 9 2023
pubmed: 11 9 2023
entrez: 11 9 2023
Statut: epublish

Résumé

Over recent years, [ This study employed the TOol for PArtcile Simulation (TOPAS) based on the Geant4 simulation toolkit. Simulation of the nuclear DNA and damage scoring were performed using the TOPAS-nBio extension of TOPAS. DNA repair was modeled utilizing the Python-based program MEDRAS (Mechanistic DNA Repair and Survival). Five different cell geometries of equal volume and two radionuclide internalization assumptions as well as two cell arrangement scenarios were investigated. The radionuclide activity (number of source points) was adopted based on SPECT images of patients undergoing the above-mentioned therapies. Based on the simulated dose-effect curves, the RBE of In this work, the consideration of DNA repair of the damage from [

Identifiants

pubmed: 37695374
doi: 10.1186/s40658-023-00567-2
pii: 10.1186/s40658-023-00567-2
pmc: PMC10495309
doi:

Types de publication

Journal Article

Langues

eng

Pagination

53

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : Research Training Group GRK 2274
Organisme : Bundesministerium für Bildung und Forschung
ID : 02NUK065C
Organisme : Bundesministerium für Bildung und Forschung
ID : 02NUK065C

Informations de copyright

© 2023. Springer Nature Switzerland AG.

Références

J Transl Med. 2023 Feb 24;21(1):144
pubmed: 36829143
Phys Med Biol. 2020 Nov 12;65(22):225007
pubmed: 33179608
J Nucl Med. 2022 Sep;63(9):1441-1449
pubmed: 35145016
Appl Radiat Isot. 2001 Jul;55(1):89-96
pubmed: 11339536
Phys Med Biol. 2021 Jul 30;66(15):
pubmed: 34280910
Cells. 2020 Oct 21;9(10):
pubmed: 33096754
Pharmaceuticals (Basel). 2015 Jun 10;8(2):321-36
pubmed: 26066613
Ann ICRP. 2003;33(4):1-117
pubmed: 14614921
Med Phys. 2010 Jan;37(1):311-21
pubmed: 20175494
Phys Med Biol. 2008 Sep 7;53(17):4825-53
pubmed: 18701772
Phys Med. 2019 Jun;62:152-157
pubmed: 31109825
Phys Med. 2020 Apr;72:114-121
pubmed: 32247964
J Nucl Med. 2009 Mar;50(3):477-84
pubmed: 19258258
Sci Rep. 2017 Sep 7;7(1):10790
pubmed: 28883414
Radiat Res. 2014 Jan;181(1):90-8
pubmed: 24502376
Mutat Res. 2011 Jun 3;711(1-2):28-40
pubmed: 21281649
Phys Med Biol. 2022 Jul 08;67(14):
pubmed: 35714599
Cancers (Basel). 2022 Feb 24;14(5):
pubmed: 35267481
N Engl J Med. 2021 Sep 16;385(12):1091-1103
pubmed: 34161051
Med Phys. 2018 Jun 14;:
pubmed: 29901835
Phys Med. 2015 Dec;31(8):861-874
pubmed: 26653251
Med Phys. 2012 Nov;39(11):6818-37
pubmed: 23127075
Phys Med Biol. 2006 Jun 7;51(11):2801-12
pubmed: 16723767
Radiat Res. 2020 Jul 8;194(1):9-21
pubmed: 32401689
Phys Med Biol. 2021 Aug 31;66(17):
pubmed: 34384060
Sci Rep. 2017 Sep 20;7(1):11923
pubmed: 28931851
Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):518-528
pubmed: 35926719
J Nucl Med. 2017 Oct;58(10):1624-1631
pubmed: 28408529
Sci Rep. 2016 Sep 14;6:33290
pubmed: 27624453
J Nucl Med. 2022 May;63(5):761-769
pubmed: 34503959
Radiat Res. 2022 Sep 1;198(3):207-220
pubmed: 35767729
Med Phys. 2010 Sep;37(9):4692-708
pubmed: 20964188
Radiat Res. 2019 Feb;191(2):125-138
pubmed: 30609382
EJNMMI Phys. 2020 May 19;7(1):33
pubmed: 32430671
Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1280-1290
pubmed: 36629878
Int J Radiat Biol. 2021;97(9):1217-1228
pubmed: 34232830
Cancers (Basel). 2022 Jan 18;14(3):
pubmed: 35158731
Clin Cancer Res. 1997 Jan;3(1):81-5
pubmed: 9815541
Med Phys. 2003 Jul;30(7):1926-31
pubmed: 12906211
Phys Med. 2017 Jan;33:207-215
pubmed: 28017738
Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3627-3638
pubmed: 35556158
J Nucl Med. 2010 Feb;51(2):311-28
pubmed: 20080889
EJNMMI Phys. 2023 Feb 9;10(1):11
pubmed: 36757516
Phys Med Biol. 2021 Sep 03;66(17):
pubmed: 34412044
Med Phys. 2004 Jul;31(7):2107-18
pubmed: 15305464
Phys Med Biol. 2009 May 21;54(10):3217-29
pubmed: 19420426
Radiat Prot Dosimetry. 2015 Sep;166(1-4):38-43
pubmed: 25883312
Med Phys. 1999 Dec;26(12):2597-601
pubmed: 10619245
Phys Med. 2016 Oct;32(10):1187-1200
pubmed: 27659007
Cancer Nanotechnol. 2021;12:
pubmed: 35663252
Med Phys. 2021 Jul;48(7):4004-4016
pubmed: 33959981

Auteurs

Mikhail Rumiantcev (M)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany. mikhail.rumiantcev@med.uni-muenchen.de.

Wei Bo Li (WB)

Federal Office for Radiation Protection, Medical and Occupational Radiation Protection, Oberschleißheim, Germany.

Simon Lindner (S)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.

Grigory Liubchenko (G)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.

Sandra Resch (S)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.

Peter Bartenstein (P)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.

Sibylle I Ziegler (SI)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.

Guido Böning (G)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.

Astrid Delker (A)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.

Classifications MeSH